Original news and analysis on international IP policy
Une analyse des pratiques et des politiques impliquant la propriété intellectuelle, le transfert de technologie et le développement démontre la difficulté à parvenir à une corrélation positive entre les différents domaines, écrit Cheikh Kane.
A group of policymakers and other experts met this month in Geneva to discuss counterfeit and unsafe products and wrestled with possible balanced solutions to the problem. The event was hosted by the United States mission and supported by the US Chamber of Commerce. It included US Ambassador to the UN Betty E. King, among dozens of others.
Key international agencies for health, trade and intellectual property on Friday jointly organised a symposium on access to medicines in an effort to gather information and expertise as a basis of a collaborative response to the challenges of public health.
Innovation is a key factor in economic growth but is not only about research as it is a system with many different interacting parts including R&D as one of those elements, a senior developed nations group representative said this week. Governments need to promote policies that integrate the cross-cutting nature of innovation and favour evidence based decision making, he said.
Climate-friendly technologies are only rarely being transferred to developing countries, and then primarily to a small handful of emerging market economies, said the findings of a study presented today.
That the changing global climate requires urgent response, and that this response will most likely include technology, is largely agreed. But what role intellectual property rights play in making sure that technology exists and is available is still not yet fully understood.
An agreement on international intellectual property rights enforcement now under negotiation in Lucerne, Switzerland runs the risk of ushering in a new and undemocratic precedent for international policymaking that could have long-term damaging effects on critical public policy issues, non-negotiating government representatives and civil society advocates said this week.
Member states at the World Intellectual Property Organization late Thursday night were unable to reach agreement on a draft chair’s conclusions text summarising a four-day WIPO copyright committee meeting, crashing the prospect of swift progress on improving international access to literary material for the visually impaired.
While World Trade Organization members met with their usual stasis last week on a mandated register for geographical indications, industry proponents of GIs continued lobbying to raise the awareness of delegates of countries not historically concerned with this form of intellectual property protection.
After two days of lively discussion, members of a World Trade Organization committee this week agreed to devote a day in October to an in-depth discussion on a waiver to WTO intellectual property rules aimed at boosting access to medicines for poor countries. In addition, some member countries presented concerns about the possible effect of a global enforcement push by developed countries and the Anti-Counterfeiting Trade Agreement (ACTA) under negotiation outside WTO, while ACTA proponent countries sought to allay fears.
"Information is the lifeblood of development," says the government of Rwanda in a recently-adopted intellectual property policy, part of the country’s comprehensive development strategy. The new policy attempts to integrate Rwanda into the international IP system while simultaneously safeguarding the freedom it needs to drive its own innovation system.
In the past two years, China has acted to improve the protection of intellectual property rights with a need for continuing effort, a World Trade Organization report has found, but the country came under criticism this week from key trading partners such as the United States and the European Union for not providing adequate enforcement and for self-serving innovation practices.
World Health Organization members today took an important step closer to finding new ways to finance research and development into diseases afflicting developing countries.